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Abstract
Induced pluripotent stem (iPS) cells derived from terminally differentiated human fibroblasts are
re-programmed to possess stem cell like properties. However, the extent to which iPS cells exhibit
unique properties of the human embryonic stem (hES) cell cycle remains to be established. Human
ES cells are characterized by an abbreviated G1 phase (~2.5 h) and accelerated organization of
subnuclear domains that mediate the assembly of regulatory machinery for histone gene
expression [i.e., histone locus bodies (HLBs)]. We therefore examined cell cycle parameters of
iPS cells in comparison to hES cells. Analysis of DNA synthesis (BrdU incorporation), cell cycle
distribution (FACS analysis and Ki67 staining) and subnuclear organization of HLBs [immuno-
fluorescence microscopy and fluorescence in situ hybridization (FISH)] revealed that human iPS
cells have a short G1 phase (~2.5 h) and an abbreviated cell cycle (16–18 h). Furthermore, HLBs
are formed and reorganized rapidly after mitosis (within0.5 to 1.5 h). Thus, reprogrammed iPS
cells have cell cycle kinetics and dynamic subnuclear organization of regulatory machinery that
are principal properties of pluripotent hES cells. Our findings support the concept that the
abbreviated cell cycle of hES and iPS cells is functionally linked to pluripotency.
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Introduction
Programming of embryonic cells occurs concomitant with phenotype-commitment during
mammalian development. Reprogramming of differentiated cells to a pluripotent state can
be achieved by somatic cell nuclear transfer (Jaenisch and Young, 2008; Blelloch et al,
2006), or expression of defined sets of transcription factors (e.g. Oct4, Sox2, KLF4 and
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cMyc) (Hockemeyer et al, 2008; Takahashi and Yamanaka, 2006; Brambrink et al, 2008;
Maherali and Hochedlinger, 2008; Park et al, 2008; Maherali et al, 2007; Wernig et al, 2007;
Okita et al, 2007; Takahashi et al, 2007; Yu et al, 2007). However, there are biological
variations in established iPS lines with respect to marker gene expression, colony
morphology, cell culture parameters, teratoma formation and ability to differentiate (Chin et
al, 2009; Daley et al, 2009; Meissner et al, 2008). This biological variation may relate to
differences in epigenetic modifications (e.g., CpG methylation), reprogramming procedures,
as well as variations in cell culture conditions and laboratory environment. In addition,
embryonicstem cells may have a naïve pluripotent phenotype or ‘primed’ pluripotent state
(Hanna et al, 2010; Nichols and Smith, 2009; Tesar et al, 2007; Brons et al, 2007).
Therefore, stringent functional tests and standards have been established that characterize
the multi-lineage potential of hES and induced pluripotent stem (iPS) cells (Daley et al,
2009; Maherali and Hochedlinger, 2008).
Human embryonic stem (hES) cells have an abbreviated cell cycle of 16–18 hours with a
very short G1 phase (2–3 hours)(Becker et al, 2006; Becker et al, 2007). Considering the
plasticity of iPS and hES cell phenotypes, it is important to determine whether fidelity of
pluripotent cell cycle control has been re-established in iPS cells. Unlike normal somatic
cells, hES cells are competent to initiate two consecutive S phases in the absence of external
growth factors and sustain an abbreviated cell cycle through autocrine mechanisms (Becker
et al, 2010b; Becker et al, 2010a). Thus, hES cells are pre-mitotically committed to initiate a
new round of cell division. Differentiation of hES cells alters cell cycle kinetics by
lengthening G1 within 72 h suggesting that the shortened G1 phase of the hES cell cycle is
functionally coupled with the pluripotent state (Becker et al, 2010b; Becker et al, 2010a).
We propose that reprogramming should not only involve the resetting of signaling pathways
and epigenetic modifications to a basal state that supports pluripotency, but should also re-
establish the unique abbreviated cell cycle that characterizes pluripotent hES cells. Indeed,
incomplete reprogramming at imprinted loci has been observed in iPS lines (Stadtfeld et al,
2010) and assessment of cell cycle kinetics may represent a useful proxy for successful
reprogramming.
As in somatic cells, histone H4 gene expression is cell cycle regulated in hES cells. In both
cell types, key histone gene regulatory factors (e.g., Nuclear Protein, ataxia-telangiectasia
locusp220NPAT) are organized in a limited number (two or four depending on the stage of
cell cycle) of subnuclear microenvironments (‘foci’) designated Histone Locus Bodies
(HLBs) (Becker et al, 2007; Ghule et al, 2007; Ghule et al, 2008; Bongiorno-Borbone et al,
2008). HLBs architecturally integrate transcriptional initiation and 3′ end processing of
histone gene transcripts. Assembly is carefully orchestrated with recruitment and/or CDK
mediated phosphorylation of HLB components at sequential sub-stages of G1. Because G1
is shortened in hES cells, HLBs organize rapidly following mitotic division to achieve the
necessary competency for expression of histone genes during S phase (Becker et al, 2007;
Ghule et al, 2007; Ghule et al, 2008). The accelerated and cell cycle dependent organization
of HLBs provides a key spatio-temporal parameter that is characteristic of the abbreviated
G1 of pluripotent hES cells. Here, we establish that, consistent with fidelity of
reprogramming to pluripotency, accelerated cell kinetics and subnuclear assembly of HLBs
are acquired in iPS cells with restoration of the pluripotent state.
Materials and Methods
Cell Culture
The human embryonic stem (hES) cell line H9 (WA09) (WiCell Research Institute Madison,
WI) and induced pluripotent stem (iPS) cell lines A6 and D1 (Hockemeyer et al, 2008) were
maintained under non-differentiating conditions and analyzed between passages 35 and 70.
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Cells were routinely examined for presence of the stem cell markers Oct-4, SSEA-3 and
SSEA-4 (Supplementary Fig. 2). Karyotyping was performed to establish that the cells
retained a normal complement of chromosomes (Supplementary Fig. 2). Retention of
pluripotency was evaluated by the ability of cells to form embryoid bodies.
Cells were maintained either on inactivated mouse embryonic fibroblasts or BD Matrigel™
(BD Biosciences) coated plates in either hES cell medium or mTeSR®1 (Stem Cell
Technologies, Vancouver, Canada) respectively. Human ES cell Media consists of 80%
Dulbecco’s modified Eagle’s medium (DMEM)/F12 (Gibco/Invitrogen, Carlsbad, CA), 20%
KnockOut-Serum Replacement (KO-SR), 2 mM L-glutamine, 1% non-essential amino
acids, 0.1 mM β-mercaptoethanol, 4 ng/ml basic fibroblast growth factor (bFGF) (all from
Invitrogen) at 37°C, 5% CO2 and high humidity. Mouse embryonic fibroblasts used as
feeder cells were isolated and prepared as described in Becker et al (Becker et al, 2006). The
hES/iPS medium was changed daily, and the cells were replated every 6–7 days by
incubating with collagenase Type IV (1 mg/ml) (Invitrogen) for 5–10 min at 37°C followed
by mild mechanical disruption. Cells were allowed to establish robust colonies before they
were used for experimental analysis.
For comparison with hES cells, we examined normal diploid human lung fibroblasts TIG1
cells that were maintained in minimum essential medium (MEM) supplemented with 10%
FBS (both GIBCO/Invitrogen), 2 mM L-glutamine, 100 units/ml penicillin, and 100 μg/ml
streptomycin (both Invitrogen) at 37°C and 5% CO2 in 10 cm tissue culture dishes.
Antibodies
The antibody working dilutions and suppliers are as follows: monoclonal p220NPAT (mouse
monoclonal, 1:1000, BD Biosciences), polyclonal p220NPAT (rabbit polyclonal, 1:1000)
(Ghule et al, 2007), LSM10 (mouse monoclonal, 1:500, Biomatrix Research), FLASH
(rabbit polyclonal) (Bongiorno-Borbone et al, 2008; Yang et al, 2009). Secondary antibodies
were goat anti-mouse Alexa 488, goat anti-rabbit Alexa 488, goat anti-mouse Alexa 594,
goat anti-rabbit Alexa 594 (all 1:800 dilution in 1X PBSA). For FISH secondary antibody
used is anti-DIG rhodamine (Roche) (1:500 in 4X SSC/1%BSA).
Mitotic Synchronization
At day 3 after plating, both hES and iPS cells were grown either on coverslips or 6-well
plates coated with either inactivated mouse feeder cells or BD Matrigel™ and were
synchronized by incubation with 200 ng/ml Nocodazole (Sigma) for 16 h(Becker et al
2006). The mitotic inhibitor was removed by repeated washes with regular incomplete
DMEM-F12medium, replenished with either fresh hES or mTeSR®1 media and cultures
were returned to the incubator. Samples were taken at the indicated time points after
removal of Nocodazole.
BrdU Incorporation Assays
Incorporation of 5–bromo–2′ –deoxy–uridine (BrdU) (Roche Diagnostics Corporation/
Roche Applied Science, Indianapolis, IN) into actively proliferating or synchronized human
iPS, hES and TIG1 fibroblast cells, was determined. Cells were grown on coverslips and
were allowed to incorporate BrdU for 30 min at 37°C. Cells were then fixed with ethanol
and 50 mM glycine (pH 2.0) for 20 min at −20°C. Subsequent detection of BrdU was
accomplished using antibodies for BrdU (1:10) according to the manufacturer’s instructions
and visualized by immunofluorescence microscopy.
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Immunofluorescence (IF) Microscopy and Fluorescence in Situ Hybridization (FISH)
Human iPS or hES cells were grown on coverslips. IF and FISH was carried out as
described previously (Ghule et al, 2007; Ghule et al, 2008). Cells were viewed under an
epifluorescence Zeiss axioplan 2 microscope and images were captured using a Hamamatsu
(C4742- 95) charged coupled device (CCD) camera and analyzed by Metamorph imaging
software (Universal Imaging). All images were captured at 63X or 100X magnification
unless noted otherwise.
Western Blot Analysis
Human iPS and hES cell lysates were made in lysis buffer [20 mM Tris-HCl pH 6.8, 0.15 M
NaCl, 1% NP-40, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM β-
glycerol phosphate, 1X Complete (Roche), 25 mM MG132, 1X phosphatase inhibitor
cocktails I and II (Calbiochem)]. Cells were incubated 5 min on ice and sonicated for 5 sec 4
times. After centrifugation at 16,100g for 15 min the supernatant was collected and protein
concentration was determined by Bradford assay (Bio-Rad). Total cellular protein (25 to 40
μg) was loaded onto 10% sodium dodecyl sulfate (SDS)-polyacrylamide gels and transferred
to a polyvinylidene fluoride (PVDF) Immobilon-P membrane (Millipore) for 30 min using a
semi-dry blotting apparatus. Immunodetection was performed with appropriate antibody
dilutions and the Western Lightning Chemiluminescence Reagent Plus (Perkin Elmer Life
Sciences). The following antibodies were used cyclin B1 (H-433), CDK2 (M2), (all from
Santa Cruz Biotechnology), cyclin E (HE-12) (BD Bioscience, San Jose, CA) and HiNF-P
(Mitra et al, 2003).
cDNA synthesis and real time quantitative PCR (qPCR)
Total RNA was isolated using TRIzol from actively proliferating or mitotically
synchronized and released human ES, iPS and TIG1 cells, subjected to DNase I digestion
and purified by column chromatography (DNA-free RNA Kit, ZYMO Research, Orange,
CA) or the Qiagen RNeasy Plus Mini Kit (Qiagen, Valencia, CA). Purified RNA was used
to prepare cDNA with the SuperScript-III First-Strand Synthesis System (Invitrogen).
Quantitation was determined using a 7300 sequence detection system (Applied Biosystems,
Foster City, CA) and SYBR Green chemistry (iTaq SYBR Green Supermix with ROX,
BioRad, Hercules, CA). The relative mRNA expression was determined by the ΔΔCT
method. Primers are presented as Supplementary Table.
Statistical Analysis for Q-RT-PCR
The effect of time was evaluated by fitting general linear mixed models (McLean et al,
1991) for each gene with experiment as a random effect. In the presence of significant time
effects pairwise comparisons for pairs of time points were evaluated using Tukey’s HSD test
(Daniel, 1990) performed on differences of least squares means from the model.
The distributional characteristics of the delta Ct were evaluated by analysis of model
residuals using the Kolmogorov-Smirnov goodness of fit test for normality (Daniel, 1990)
and by graphical inspection of frequency histograms of model residuals. The levels were
transformed by natural logarithms and retested to confirm compliance with the distributional
assumptions of the mixed model analysis (McLean et al, 1991). Analyses were performed
using the SAS statistical software package (SAS Institute Inc., 2008) using the Mixed
procedure (SAS Institute Inc., 1997; Singer, 1999).
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The length of G1 phase in human iPS cells is reduced
We examined the growth properties and cell cycle parameters of human iPS cells (A6 and
D1) (Hockemeyer et al, 2008) in comparison to hES cells (H9/WA09) and/or normal
somatic cells (TIG1 fibroblasts). The subnuclear organization of Ki67 in human ES cells
shows a proliferation-and cell cycle stage-specific immunostaining pattern (e.g., ranging
from multi-focal in G1 to monofocal in G2 phase) that permits in situ assessment of cell
cycle distribution (Becker et al, 2006; Ghule et al, 2007; Solovei et al, 2005). All cells
stained positively with the human-specific Ki-67 antibody indicating that all cells in our
asynchronous iPS and hES cultures are actively proliferating. More importantly, we observe
similarities in Ki67 immunostaining that reflect a virtually indistinguishable cell cycle
distribution and that the majority of human iPS and hES cells (>50%) show S-phase specific
Ki67 staining patterns (Fig 1A). Furthermore, BrdU pulse labeling assays, which determine
the fraction of cells in S phase, reveal that the percentage of BrdU positive iPS cells (A6 =
60%) is similar to that of hES cells (H9 = 65%) but different from somatic cells
(TIG1=14%) (Fig. 1B and Fig. 1C). Thus, similar to hES cells, a substantial fraction of iPS
cells (>50%) progresses through S phase.
We directly evaluated the length of G1 phase in iPS cells using BrdU incorporation assays
upon release of mitotically synchronized human A6 and/or D1 iPS cells (Fig. 2 and
Supplementary Fig. 1), H9 ES (Ghule et al, 2008) and/or TIG1 cells from a nocodazole-
imposed cell cycle arrest. In addition, we monitored cell cycle progression using stage-
specific RNA and protein markers, as well as FACS data (Fig. 3). Strikingly, the earliest
robust incorporation of BrdU in A6 and D1 iPS cells is evident within 3h after release from
mitosis establishing that cells have progressed beyond the G1/S transition (Fig. 2 and
Supplementary Fig. 1). This finding immediately indicates that iPS cells have an abbreviated
G1 period relative to somatic cells and rapidly enter S-phase after mitosis. This
interpretation is corroborated by the relative expression of cell cycle genes at the mRNA
(e.g., histone H4)(Fig. 3A) or protein levels (e.g., cyclin E)(Fig. 3C), as well as FACS
analysis (e.g., ratio of 4n to 2n cells)(Fig. 3D). The up-regulation of histone H4 mRNA
levels at the G1/S phase transition (Fig. 3A) establishes that histone gene expression is cell
cycle regulated in human iPS cells.
The extent of BrdU incorporation in iPS cells increases with cell cycle progression. By 8
hours after release from mitosis, >90% of iPS cells are BrdU positive, reflecting active
engagement in DNA synthesis (i.e., mid- to late S phase). We have made similar
observations in hES cells (Becker et al, 2006). In contrast, substantial BrdU incorporation
for normal somatic cells (Wi-38 and TIG1 fibroblasts) is not observed until 12 hr after
mitotic release (see Fig. 6B below)(Ghule et al, 2008) as reflected by corresponding changes
in the expression of cell cycle related genes (Fig. 3B). Our data clearly demonstrate that
reprogramming of somatic cells to the pluripotent state results in the acquisition of an
abbreviated G1 phase of the cell cycle.
Assembly of HLBs During the Abbreviated iPS Cell Cycle is Accelerated
One key question is whether the abbreviated cell cycle of iPS cells is accompanied by the
rapid assembly of subnuclear regulatory domains (i.e., HLBs) required for histone gene
expression during S phase as normally occurs in hES cells. Therefore, we investigated the
cell cycle dependent organization of HLBs where histone gene transcription factors (e.g.,
p220NPAT) are localized together with key proteins involved in 3′ end processing of histone
pre-mRNA (e.g., LSM10, FLASH) at histone gene clusters (i.e., 6p21 and 1q21). Human ES
cells have either two or four foci during interphase, but there are no foci during or
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immediately after mitosis. Two of these foci are always associated with the two alleles of
the major histone gene cluster on chromosome 6p21, while the remaining two foci reflect
association with the minor 1q21 cluster that is not microscopically evident until cells enter S
phase (Ghule et al, 2008; Ghule et al, 2009). We examined HLB organization in actively
proliferating asynchronous iPS and hES cells, as well as in mitotically synchronized cells
progressing through G1 into S phase. In both asynchronous iPS and hES cells, some cells
display only two HLBs, while the majority of cells (>60%) display four HLBs (Fig. 4 and
(Ghule et al, 2008) for hESs) that mirror the fraction of S phase cells as determined by cell
cycle stage-specific Ki67 staining, BrdU incorporation and FACS analysis (Figs. 1 and 2,
and Supplementary Fig. 1). Thus, the overall appearance of HLBs is similar in hES and iPS
cells.
Control of histone gene expression requires tight functional, temporal and spatial inter-
relationships among the co-activator p220NPAT, the histone pre-mRNA processing factor
LSM10, the architectural protein FLASH (Yang et al, 2009) and histone gene loci at HLBs
(Miele et al, 2005; Bongiorno-Borbone et al, 2008; Ghule et al, 2007; Ghule et al, 2008).
Loss of stringent cell cycle control in cancer cells may disrupt this dynamic organization of
HLBs (Ghule et al, 2009) and thus represents an architectural parameter to monitor fidelity
of cell cycle control in reprogrammed iPS cells. In both A6 and D1 iPS cell lines, we find
that p220NPAT foci co-localize with both LSM10 and FLASH at the 6p21 histone gene
cluster in all cells except during and immediately after mitosis (Fig. 4). Hence, the
machinery for both initiation and processing of histone pre-mRNAs is spatially linked to
HLBs in iPS cells.
We directly addressed whether reprogramming of the abbreviated G1 phase in human iPS
cells also restores the accelerated assembly of HLBs as observed in hES cells (Ghule et al,
2008). We mitotically synchronized iPS cells (A6) (Fig. 5) and confirmed effectiveness of
synchronization by Ki-67 immunostaining (Fig. 5), BrdU incorporation and FACS analysis
(e.g., see Figs. 2 and 3). The iPS cells enter S phase within 3 h after release from nocodazole
imposed mitotic block (Fig. 5), thus establishing similar kinetics of cell cycle progression
through G1 and S phase observed for hES cells (Ghule et al, 2008). Within 1h after mitosis,
neither p220NPAT nor LSM10 exhibits focal organization in early G1 cells, and there is no
evidence of association with histone gene loci in iPS cells at this time point. However, in
mid to late G1 (2 h after release) two p220NPAT foci are formed and by early S phase four
foci are evident (at 4h). Co-localization of p220NPAT with both LSM10 and histone gene
loci (e.g., 6p21) marks the formation of HLBs which are maintained throughout S-phase and
until mitosis (Fig. 5). Taken together, the results show that the abbreviated G1 phase (~2.5h)
of human iPS cells is accommodated by a rapid assembly of histone gene transcription and
pre-mRNA processing factors at HLBs following mitosis, as is observed in hES cells.
Reprogrammed Pluripotent Cells Have an Abbreviated Cell Cycle of 16–18 Hours
Our results thus far show that iPS cells have a short G1 phase suggesting that the overall cell
cycle length may be reduced. To assess the time span between successive S phases as a
measure of cell cycle length, we followed BrdU incorporation during DNA synthesis after
release of nocodazole-synchronized iPS cells (A6) along with hES (H9) cells for 24 h (Fig.
6). There are no BrdU positive cells between O h and 2 h after mitotic release, but BrdU
incorporation is evident after 4 h in both iPS cells (A6 = 60%) and hES cells (H9=51%). The
peak of robust BrdU incorporation (>80–90% BrdU positive cells) occurs between 8and 10
h after mitotic release (Fig. 6). Strikingly, 18 h after mitotic release the percentage of BrdU
incorporation is minimal in both iPS cells (A6=4%) and hES (H9=6%) cells (Fig. 6). Active
DNA synthesis increases again between 18 and 21h after mitotic release indicating that both
iPS and hES cells have entered a second cell cycle (Fig. 6). Furthermore, by 24 h after
mitotic release more than 60% of human iPS and hES cells show robust BrdU incorporation,
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indicating progression through a second S phase. Our findings demonstrate that
reprogrammed iPS cells have a cell cycle duration of approximately 16 to 18 h, which is
indistinguishable from that of hES cells.
Discussion
The universal property of all stem cells is their capacity for self-renewal through cell
division. Our recent studies showing that pluripotency of hES cells is functionally linked to
the abbreviated cell cycle (Becker et al, 2006; Becker et al, 2010b; Ghule et al, 2007; Ghule
et al, 2008) predicts that acquisition of the induced pluripotent state upon reprogramming of
differentiated somatic cells should affect cell cycle kinetics. Indeed, here we find that two
different iPS lines have a reduced cell cycle time due to a shortened G1 phase (2–3 h), thus
resembling the pluripotent hES cell cycle. Both hES cells and human iPS cells exhibit rapid
post-mitotic appearance of BrdU positive cells, S-phase specific immunostaining of Ki-67
and >2n DNA content by FACS. By examining BrdU incorporation in successive cell cycle
stages, we conclusively establish that, indistinguishable from the self-renewal cell cycle of
human ES cells, the cell cycle length of reprogrammed pluripotent stem cells is abbreviated
(16–18 h). Therefore, we conclude that the reprogramming of somatic cells to the induced
pluripotent state restores the abbreviated G1 phase and expedited cell cycle.
Recent studies by Hanna and colleagues using mouse cell lines (Hanna et al, 2010) have
shown that the doubling time for pluripotent stem cells is 12 to 15 h in reasonable agreement
with the cell cycle time we have established for human ES cells. When hES cells
differentiate, the cell cycle duration lengthens to >24 h, which is the typical cell cycle of a
differentiated somatic cell (Becker et al, 2010b). Therefore, we postulate that the pluripotent
self-renewal cell cycle is fundamentally distinct. We note that cell cycle length is only a
hallmark of pluripotency provided that measurements of cell cycle kinetics are performed
under standard cell culture conditions that permit autocrine signaling (Becker et al, 2010b).
The study by Hanna and coworkers (Hanna et al, 2010) revealed that some iPS and hES
lines have a doubling time of >24 h, which may reflect differences in cell culture conditions,
as well as in cell death and survival. Interestingly, optimization of reprogramming and cell
culture conditions of hES and iPS lines can reduce doubling time to ~19 h (Hanna et al,
2010), in fair agreement with our direct measurement of cell cycle times (i.e., 16–18 h).
Another property that should be shared by all pluripotent stem cells is that they stringently
regulate histone gene expression to support requirements for histone proteins to package
newly replicated DNA during S phase (Becker et al, 2006; Becker et al, 2007). This ability
must be retained concomitant with competency to establish the rapid and staged assembly of
histone regulatory factors, including HiNF-P and its co-activator p220NPAT, which are both
key components of the regulatory machinery for histone H4 gene expression that operates at
HLBs (Mitra et al, 2003; Miele et al, 2005; Zhao et al, 1998; Ma et al, 2000; Zhao et al,
2000; Ghule et al, 2007; Ghule et al, 2008). Our data indicate that expression of histone
genes is cell cycle regulated and involves the accelerated spatio-temporal assembly of HLBs
both in human iPS and hES cells. Similar to hES cells but in contrast to somatic cells, HLBs
are rapidly formed immediately after mitosis in iPS cells with recruitment of p220NPAT, as
well as the factors required for 3′ end processing of histone pre-mRNAs (e.g., LSM10 and
FLASH) at the histone gene loci (6p21 and 1q21). The similarities in the rapid post-mitotic
appearance of HLBs in both human iPS and hES cells provide an informative subnuclear
parameter to define the pluripotent cell cycle in both native and reprogrammed stem cells.
Furthermore, despite temporal differences in assembly between pluripotent and
differentiated cells, the focal organization of histone gene regulatory machinery as histone
locus bodies in lineage committed cells, blastocyst-derived embryonic stem cells and
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reprogrammed pluripotent cells is consistent with an architectural requirement for a nuclear
microenvironment that supports histone biosynthesis.
In conclusion, our study establishes key cell cycle parameters that are shared between
pluripotent iPS and hES cells, and that provide self-renewal-related standards to assess
reprogramming of somatic cells to the pluripotent state. We have established the utility of
several well-documented nuclear markers (i.e., p220NPAT, Ki67 and BrdU incorporation)
that can provide in situ insight into cell cycle kinetics. These parameters facilitate in
accounting for biological variation in human iPS cells derived from different sources and by
different procedures.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The majority of cells in actively proliferating human iPS lines are in S-phase. We examined
the cell cycle parameters of actively proliferating human iPS cells (A6), hES cells (H9/
WA09) and/or fibroblasts cells (TIG1). (A) IF microscopy was used to study cell cycle stage
specific subnuclear localization of Ki67 (red) by immuno-staining. DAPI staining (blue) is
used to visualize the nucleus. (B) BrdU incorporation assays using a 30-minute BrdU pulse
labeling was used to directly determine the fraction of cells in S phase in iPS and hES. IF
microscopy was used to detect the BrdU positive cells (green) and DAPI staining (blue) is
used to visualize the nucleus. (C) Graph shows percentage of BrdU positive cells in actively
proliferating cultures.
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The length of G1 phase is reduced in human iPS cells. We synchronized human iPS cell
lines A6 using the mitotic inhibitor nocodazole. BrdU incorporation assays using a 30-
minute BrdU pulse labeling was used to determine active DNA synthesis in synchronized
cells at multiple time-points following release from mitosis. IF microscopy was used to
detect the BrdU positive cells (green) and DAPI staining (blue) is used to visualize the
nucleus. Following hourly time points were used to analyze G1/S transition; 0, 1, 2, 3, 4, 5
and 8. Human iPS cells rapidly enter S-phase after mitosis (3h) and BrdU incorporation
increases with cell cycle progression with >90% of BrdU positive cells at 8h after release
from mitosis.
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Biochemical analysis of synchronized human iPS (A6 and D1), hES (H9) and/or fibroblasts
cells (TIG1) corroborate the finding that human iPS cells have an abbreviated G1 phase. (A)
The relative RNA expression of cell cycle indicators; histone H4, Cyclin E2, Cyclin B2,
HINFP and p220NPAT was analyzed using mRNA isolated from actively proliferating and
nocodazole synchronized human iPS (asynchronous [Asy], 0h [G2/M], 2h [G1] and 4h
[early S] after release) and hES cells (asynchronous [Asy], 0h [G2/M], 1.5h [G1] and 4h
[early S] after release). (B) For comparison, the relative RNA expression of some of the cell
cycle indicators; histone H4, Cyclin E2, Cyclin B2, HINFP and p220NPAT was analyzed in
actively proliferating and nocodazole synchronized human normal fibroblasts TIG1
(asynchronous [Asy], 0h [mitosis-M], 6h [G1] and 16h [S] after release). (C) Protein
expression analysis of human iPS (A6 and D1) and hES (H9) for cell cycle indicators
(Cyclin E2, Cyclin B2 and HINFP) also reveals rapid entry into S-phase. (D) FACS analysis
of synchronized human iPS (A6) and hES (H9) cells shows that within 2–3 h after exit from
mitosis cells enter S-phase. Statistical analysis is done against/compared to G2/M (Figure
3A) or M (figure 3B), except if noted otherwise (brackets). †, approaching significance
(0.05<P<0.1); *, P<0.05; **, P<0.01.
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HLBs (p220NPAT foci) are associated with histone gene transcription and processing
machinery at histone gene clusters in actively proliferating human iPS (A6 and D1). IF
microscopy images were obtained using antibodies against p220NPAT (green) co-stained
with either Ki67(red), LSM 10 (red), FLASH (red) or a DIG-labeled FISH probe adjacent to
the histone gene cluster on 6p22(red). DAPI staining (blue) is used to visualize the nucleus.
There are typically 2 or 4 HLBs as denoted by p220NPAT foci depending on the cell cycle
stage and they co-localize with factors mediating histone pre-mRNA processing at histone
gene clusters.
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HLBs assemble rapidly in human iPS cells. Synchronized human iPS cell lines A6 were co-
stained with HLB marker p220NPAT (green) and either (B) LSM 10 (red), or (C) a DIG-
labeled FISH probe adjacent to the histone gene cluster on 6p22(red). IF microscopy was
performed at different time points (0h, 2h and 4h) following exit from mitosis. (A) Ki-67
(red) staining was used to monitor cell cycle. DAPI staining (blue) is used to visualize the
nucleus. We observe that the histone gene transcription and pre-mRNA processing factors
are associated with histone gene cluster at HLBs as soon as they are formed at 2h after exit
from mitosis.
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The length cell cycle is abbreviated in human iPS cells (16–18h). We synchronized human
iPS cell line A6, hES (H9) and/or normal fibroblasts (TIG1) using the mitotic inhibitor
nocodazole and followed the cells through consecutive cell cycles for up to 24h after exit
form mitosis. BrdU incorporation assays using a 30-minute BrdU pulse labeling were used
to monitor active DNA synthesis multiple time-points. (A) hES (H9) cells; (B) iPS (A6) IF
microscopy was used to detect the BrdU positive cells (green) and DAPI staining (blue) is
used to visualize the nucleus. Following hourly time points were used to analyze the entire
cell cycle; 0, 2, 4, 6, 8, 10, 12, 15, 18, 21 and 24. Human iPS cells rapidly enter S-phase
after mitosis (3h) and BrdU incorporation increases with cell cycle progression with >90%
of BrdU positive cells at 6–8h after release from mitosis. BrdU incorporation drops to as low
as 5–10% at 18h and shows gradual increase from 21–24h (>50% BrdU positive cells)
showing entry into the second S-phase. (C) The graphs show percentage of BrdU positive
fraction (S-Phase) in synchronized human iPS cell line A6, hES (H9) cells and normal
fibroblasts (TIG1). At least 100 cells were counted microscopically for each time point.
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